How many clinical trials are studying Melatonin?

6 recruiting trials in our tracked data involve Melatonin.

What conditions is Melatonin being studied for?

In our tracked recruiting trials, Melatonin is being studied in trials for Bipolar Disorder, Alzheimer's disease, Anxiety.

Melatonin: clinical trials recruiting now

Q: Is Melatonin FDA-approved?

Yes. According to the FDA drug label available through openFDA, Melatonin is an FDA-approved drug.

Recruiting trials

Conditions studied

US states with sites

Countries

FDA drug label

FDA-approved: Yes. Melatonin appears in the FDA drug-label database. Marketed as Melatonin.

FDA-approved use

USES: • For the temporary relief of symptoms including: • difficulty sleeping • jet lag These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

FDA label via openFDA

Phase breakdown

Phase 2 4 Phase 3 2 Not applicable 1

Conditions being studied

Condition	Trials
Bipolar Disorder	2
Alzheimer's disease	1
Anxiety	1
Bipolar Affective Disorder	1
Cancer	1
Cognitive Decline	1
Delayed Sleep-Wake Phase Disorder	1
Depression	1
Diabetic Neuropathy	1
Diabetic Peripheral Neuropathy	1
Diabetic Peripheral Neuropathy in Type 2 Diabetic Patients	1
Eye Cancer, Intraocular Melanoma	1
Fatigue	1
Healthy Aging	1
Melanoma	1

Recruiting trials involving Melatonin

Adjuvant Melatonin for Uveal Melanoma
NCT05502900 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
NCT05474846 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder
NCT06226025 · Phase: Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging
NCT03954899 · Phase: Not applicable (e.g. observational or device study) · Ages: 56 Years to 85 Years · Sex: All (male and female) · 1 location
Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy
NCT07036796 · Phase: Phase 2 · Ages: 40 Years to 75 Years · Sex: All (male and female) · 1 location
Melatonin Versus Placebo for Bipolar Disorder
NCT07472075 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

Common questions

Is Melatonin FDA-approved?

Yes, marketed as Melatonin.

How many recruiting trials involve Melatonin?

6 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.